Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022

Background: New multiple myeloma (MM) medications have revolutionized the treatment landscape, but they are also associated with a range of adverse events (AEs). This study aims to provide a comprehensive overview of AEs reported for four new MM medications: daratumumab, ixazomib, elotuzumab, and pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Marwan A. Alrasheed (Author), Khalid A. Alamer (Author), Mashael Albishi (Author), Abdulrahman A. Alsuhibani (Author), Omar A. Almohammed (Author), Abdulrahman Alwhaibi (Author), Abdullah N. Almajed (Author), Jeff J. Guo (Author)
Format: Book
Published: MDPI AG, 2024-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items